NS 6740

Known as: NS-6740, NS6740 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2017
01220092017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND AND PURPOSE GAT107 ((3aR,4S,9bS)-4-(4-bromo-phenyl)-3a,4,5,9b-tetrahydro-3H-cyclopenta-[c]quinoline-8-sulfonamide) is… (More)
Is this relevant?
2017
2017
Recently, α7 nicotinic acetylcholine receptors (nAChRs), primarily activated by binding of orthosteric agonists, represent a… (More)
Is this relevant?
2015
2015
The α7 nicotinic acetylcholine receptor (nAChR) is a promising drug target for a number of neurological disorders including… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Background: The α7 nicotinic acetylcholine receptor (nAChR) is an important molecular target in neuropsychiatry and oncology… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2014
2014
BACKGROUND The α7 nicotinic acetylcholine receptor (nAChR) is an important molecular target in neuropsychiatry and oncology… (More)
  • figure 1
  • figure 2
  • figure 5
  • table 1
  • figure 4
Is this relevant?
2012
2012
The anti-inflammatory properties of, particularly the α7, nicotinic acetylcholine receptors (nAChRs) in the peripheral immune… (More)
Is this relevant?
2011
2011
To conduct a quantitative PET assessment of the specific binding sites in the brain of juvenile pigs for [18F]NS10743, a novel… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
  • table 1
Is this relevant?
2009
2009
BACKGROUND AND PURPOSE Several agonists of the alpha7 nicotinic acetylcholine receptor (nAChR) have been developed for treatment… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?